Skip to content

Placing Preterm Infants in Polyethylene Bags Immediately After Birth

Placing Preterm Infants in Polyethylene Bags Immediately After Birth

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04463511
Enrollment
194
Registered
2020-07-09
Start date
2020-07-13
Completion date
2023-01-01
Last updated
2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia, Infant, Newborn, Premature

Keywords

cord clamping, hypothermia, hyperthermia, polyethylene bag

Brief summary

Primary objective: To determine if placing preterm infants in a polyethylene bag (PB) immediately after birth, before the umbilical cord is clamped, will increase the number of preterm infants with a normal temperature on admission to the Neonatal Intensive Care Unit (NICU).

Detailed description

Newly born preterm infants that develop abnormal temperature after birth have higher morbidity and mortality. Placing infants \< 32 weeks' gestation in a polyethylene bag (PB) in the delivery room (DR) reduces the rate of hypothermia on admission to the Neonatal Intensive Care Unit (NICU). Since 2012, the rate of admission hypothermia in preterm infants, placed in a PB in the DR at the National Maternity Hospital (NMH), has increased significantly. This may be as a result of heat loss while the infant remains attached to the cord. Our primary objective is to determine if placing preterm infants in a PB immediately after birth, before the umbilical cord is clamped will increase the number of preterm infants with a normal temperature on admission to the NICU.

Interventions

OTHERPolyethylene bag before the umbilical cord is clamped

11 x 16 (279mm x 406mm) sterile resealable PB (Resealable Polybag, Helapet Ltd, Bedfordshire, UK)

Sponsors

University College Dublin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

In the delivery room, the infant is randomised to application of a polyethylene bag before or after cord clamping. Neither the delivery room care provider nor the investigator are blinded to the group assignment. When the infant is stable, they are be transferred from the delivery room to the neonatal unit. The outcome assessor is the admitting nurse in the neonatal unit who will be blinded to the group assignment.

Intervention model description

Single-centre randomised controlled trail

Eligibility

Sex/Gender
ALL
Age
No minimum to 32 Weeks
Healthy volunteers
Yes

Inclusion criteria

Infants who are inborn at the National Maternity Hospital at \< 32 (up to 31+6) weeks' gestation by best obstetric estimate will be included in the study.

Exclusion criteria

* Infants with a large abdominal wall or neural tube defects * Infants with an imperforate anus * Infants to whom resuscitative measures are not initiated in the DR

Design outcomes

Primary

MeasureTime frameDescription
Temperature on admission to the Neonatal Intensive Care Unit (NICU)The primary outcome measure will be determined on admission to the NICU, before the infant is removed from the transport incubator (< 90minutes of life)Rectal temperature recorded upon arrival to the NICU, while the infant is in the transport incubator. (measured in degrees celsius)

Secondary

MeasureTime frameDescription
5 minute ApgarWithin 2 hours of birthScale (0-10)
External cardiac massage in the delivery roomWithin 2 hours of birthYes/ No, Duration
Infant temperature recordings in the delivery roomWithin 2 hours of birthMeasured with Microlife MT 1931 digital thermometer at the rectum. Recorded in degrees celsius.
Axillary temperature on admission to the NICUBetween 0-2 hours of lifeMeasured with Microlife MT 1931 digital thermometer at the rectum. Recorded in degrees celsius.
Temperature 1 hour after admissionBetween 0-2 hours of lifeMeasured with Microlife MT 1931 digital thermometer at the rectum. Recorded in degrees celsius.
Central catheter placement in first 24 hoursBetween 0-24 hours of lifeYes/no. Type and location of catheter
Intubation and mechanical ventilationTerm corrected gestation age or hospital discharge (<17 weeks)Yes/no, type and duration
Respiratory Distress SyndromeBetween 0-24 hours of lifeYes/no
Non-invasive ventilation (NIV) on the first day of life (24 hours)Between 0-24 hours of lifeYes/ no, type of NIV
Surfactant administrationDay 1 - 7 of lifeYes/ no, route of administration
Respiratory support in the DRWithin 2 hours of birthType and duration of respiratory support in the DR
Pulmonary haemorrhageTerm corrected gestation age or hospital discharge (<17 weeks)Yes/ no
Hypotension requiring inotropesTerm corrected gestation age or hospital discharge (<17 weeks)Yes/ no, inotropes, duration
Intraventricular haemorrhageTerm corrected gestation age or hospital discharge (<17 weeks)Papile classification
Periventricular leukomalaciaTerm corrected gestation age or hospital discharge (<17 weeks)Yes/ no
Necrotising enterocolitisTerm corrected gestation age or hospital discharge (<17 weeks)Bell's staging criteria
Sepsis - early onsetBetween 0-72 hours of lifeYes/ no
Sepsis - late onsetAfter 72 hours of life until term corrected or hospital discharge (maximum 16 weeks)Yes/ no
Retinopathy of prematurity requiring treatmentTerm corrected gestation age or hospital discharge (<17 weeks)Yes/ no, treatment
Oxygen requirement at 36 weeks corrected gestational age36 weeks corrected gestational ageYes/ no
Death before discharge from hospitalTerm corrected gestation age or hospital discharge (<17 weeks)Yes/ no
Pneumothorax requiring drainageTerm corrected gestation age or hospital discharge (<17 weeks)Yes/ no, needle aspiration or definitive chest drain or both

Countries

Ireland

Contacts

Primary ContactLisa K McCarthy, MB BCh BAO
lmccarthy@nmh.ie+3531637310
Backup ContactEmma A Dunne, MB BCh BAO
emma.dunne9@gmail.com+35316373100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026